The story of this versatile plant
Cannabis has been used for thousands of years in various cultures for a wide range of applications. From medicinal treatments to the production of textiles and ropes, cannabis has had a broad spectrum of uses. In Switzerland, cannabis was widespread at the beginning of the 20th century and was sold in pharmacies for medicinal purposes. This positive use contrasted sharply with its later criminalization.
The beginning of Prohibition
In the early years of the 20th century, public opinion about cannabis began to change, particularly in the United States. This was due to misinformation and the unfair association of cannabis with immigrants and marginalized communities. Sensationalist media coverage and widespread ignorance about the effects of cannabis contributed to an atmosphere of fear and paranoia that ultimately led to prohibition.
A car made of hemp
As early as 1910, Henry Ford began experimenting with the use of renewable resources like hemp for the production of fuels and plastics. In 1941, he presented the Hemp Car as the "car of the future." Its body was made from an innovative blend of hemp and soy fibers, which were significantly more impact-resistant than metal. The Hemp Car weighed only 900 kilograms, about 450 kilograms less than cars with conventional metal bodies. Despite its promising qualities, the Hemp Car was surprisingly discontinued at the end of 1941. Speculation abounds regarding conflicts between agrarian culture and industrialization, as well as the interests of the cotton and hemp industries. The Hemp Car remains a testament to Henry Ford's visionary ideas for a more sustainable world with hemp as a key raw material. Hypothetically speaking, one wonders what our world might look like today if hemp hadn't been banned and such innovations had continued to be pursued.
Racism and economic interests
Harry J. Anslinger, a bureaucrat with racist tendencies, played a crucial role in shaping cannabis legislation in the United States. He led an aggressive campaign against cannabis, fueling racist prejudices and resulting in racially discriminatory prosecution of cannabis-related offenses. Anslinger spread false information about its effects, claiming it led to violence and insanity. Simultaneously, economic interests promoted the criminalization of cannabis, as it was seen as a threat to the burgeoning plastics and paper industries. In 1951, Swiss Federal Councillor Philipp Etter, in his speech to Parliament, adopted the false statements about hemp use made by Harry J. Anslinger, head of the American Drug Enforcement Administration. Etter's views, implemented under emergency law following World War II, led to the prohibition and thus the disappearance of hemp, a native cultivated and medicinal plant. The fear of the "devil's weed," stoked in the US, was so contagious that cannabis was banned in Switzerland without any scientific basis. The opinion is that those who smoke marijuana become addicted, and drug addiction is a danger to the state.
International agreements and medical research
The 1961 Single Convention on Narcotic Drugs of the Association of Ten Nations solidified the worldwide prohibition by classifying cannabis as particularly dangerous and regulating it strictly. This ignored the nuanced aspects of the plant and its medicinal potential. Despite known therapeutic properties, medical research on cannabis was severely hampered by the prohibition, depriving millions of people of potential treatment options for decades.
Harry Anslinger and his marijuana lies
After Harry Anslinger's death, his so-called "archive" was examined, containing around 200 sensationalist stories from tabloid newspapers. Historians have scrutinized these stories and determined that 198 of them were either false or outright fabricated. Anslinger was known for his dubious methods of spreading misinformation about marijuana, thus contributing to the development of prejudice against the substance. To this day, many countries maintain prohibitions based on these lies. These views must be reconsidered and changed at the international level.
The changing cannabis legislation in Switzerland
In the years following 2000, Swiss cannabis policy underwent significant changes. During this period, "hemp shops" emerged, selling scented sachets and bath additives, but in reality offering cannabis flowers for consumption. This led to a brief period when the purchase of cannabis was legal in Switzerland. Although the popular initiative "For a sensible hemp policy with effective youth protection" was rejected in 2008, it sparked an important debate about cannabis use. A significant step regarding medical use was taken in 2011. Physicians were granted the authority to prescribe cannabis for the treatment of specific illnesses with a special permit from the Federal Office of Public Health. However, the decisive advance came in 2022 with another legislative amendment. Today, only medical professionals are authorized to prescribe cannabis and can use it to treat a wide range of conditions. This change aims to provide patients with better access to this therapeutic option. This development is a milestone and underscores the growing acceptance of the medical use of cannabis. Pilot projects for the controlled distribution of recreational cannabis are currently underway in Switzerland. These projects are intended to pave the way for possible future legalization.
Recent developments and the fight against stigma
In recent years, the world has become increasingly aware of the suffering that cannabis prohibition has caused for many patients. Many who rely on cannabis as medicine have suffered disproportionately due to the persistent stigma and criminalization. These individuals have dared to share their stories and experiences, and this has significantly contributed to influencing public opinion and paving the way for reform.
The role of patient organizations
Patient organizations like the Association MEDCAN play a crucial role in this transformation. They are passionately committed in various countries to combating stigma and refuting misinformation. The members of these organizations are often people who have experienced firsthand the positive effects of medical cannabis use. They are active advocates for legalization and work hard to influence public opinion. To bring about change internationally and protect the rights and interests of patients worldwide, the IACM Patient Council was established. This international coalition of patient organizations works together to give a voice to those affected and to change perceptions of medical cannabis. MEDCAN has also taken an active role in this coalition and regularly participates in its meetings. You can find the IACM Patient Council website here.
You too can contribute to a better future!
Become a member or support us with a donation. Together, we can be a strong voice for destigmatizing cannabis. Your support is crucial to bringing about positive change and ensuring that sick people have access to cannabis for medical use. Join us and help create a better future for everyone.
